ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Global B-cell NHL market set to reach $9.2bn by 2027 biospectrumasia
July 17, 2019CAR-T therapies, including the currently marketed Yescarta and Kymriah and the pipeline agent lisocabtagene maraleucel, are expected to result in significant revenues due to premium pricing and clinical benefit in heavily pre-treated patients
Pharma Sources Insight January 2025
